Company news
Staar Surgical Company (NASDAQ:STAA) news
Every Staar Surgical Company press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
September 10, 2026
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
September 8, 2026
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
September 2, 2026
STAAR Surgical Reports Second Quarter 2026 Results
August 12, 2026
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer
August 4, 2026
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026
July 16, 2026
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
May 13, 2026
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
May 4, 2026
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
April 8, 2026
STAAR Surgical Issues Shareholder Letter
March 3, 2026
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
March 3, 2026
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
February 25, 2026
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
February 23, 2026
FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
February 17, 2026
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
February 2, 2026
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
January 15, 2026
Alcon Terminates Agreement to Acquire STAAR Surgical
January 6, 2026
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
January 6, 2026
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
December 19, 2025
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
December 17, 2025
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transa...
December 16, 2025
Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
December 15, 2025
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
December 11, 2025
Alcon Announces Amended Merger Agreement with STAAR Surgical
December 9, 2025
STAAR Surgical Announces Expiration of Go-Shop Period
December 8, 2025
STAAR Surgical Announces Amendments to Alcon Merger Agreement
November 7, 2025
STAAR Surgical Reports Third Quarter 2025 Results
November 5, 2025
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
October 27, 2025
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
October 23, 2025
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025
October 20, 2025
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
October 16, 2025
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon
October 15, 2025
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WH...
October 8, 2025
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WH...
October 8, 2025
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
October 7, 2025
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
October 6, 2025
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAA...
October 6, 2025
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
September 30, 2025
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks i...
September 26, 2025
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote "AGAINST" Proposed Acquisition by Alcon
September 24, 2025
STAAR Surgical Announces Expiration of "Window Shop" Period; No Competing Acquisition Proposals Received
September 22, 2025
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
September 22, 2025
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
September 16, 2025
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
September 2, 2025
STAAR Surgical Reports Second Quarter 2025 Results
August 6, 2025
Alcon Agrees to Acquire STAAR Surgical
August 5, 2025
STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025
July 31, 2025
STAAR Surgical Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of D...
June 25, 2025
STAAR Surgical Announces Participation in Upcoming Investor Conferences
May 22, 2025
STAAR Surgical Announces $30 Million Share Repurchase Authorization
May 16, 2025